More articles from In vitro and In vivo Oncology

You have access
A preclinical study of minibody 177Lu-DOTA-IAB2 targeting PSMA for Radiopharmaceutical Therapy of Prostate Cancer
Fang Jia, Gareth Smith, Leticia Maria De Souza Cordeiro, Kelley Diaz, Ian Wilson and Alessandro Mascioni

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4027;
You have access
Preliminary evaluation of 131I-labeled ITGA5 inhibitor for targeted radionuclide therapy of pancreatic cancer xenografts
Tao Wang

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4021;
You have access
Immuno-PET using 89Zr-labeled Glypican-1 antibody: a novel theranostic probe for the antibody-drug conjugate treatment in pancreatic cancer
Tadashi Watabe, Sadahiro Naka, Satoshi Serada, Eku Shimosegawa and Tetsuji Naka

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4041;
You have access
The journey to a novel theranostic for prostate cancer : the preclinical study of 64Cu-DOTHA2-PSMA
Marie-Christine Milot, Ophelie Belissant Benesty, Veronique Dumulon-Perreault, Samia Ait-Mohand, Sameh Geha, Patrick Richard, Etienne Rousseau and Brigitte Guerin

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4025;
You have access
Potentiation of Immune Checkpoint Inhibition with Molecular-Targeted Radiation
Simone Kleinendorst, Peter Chandler, Egbert Oosterwijk, Mark Konijnenberg, Kwame Twumasi-Boateng, Michael Wheatcroft and Sandra Heskamp

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4039;
You have access
Bone marrow RBE for a 212Pb-conjugated anti-HER2/neu antibody
Ioanna Liatsou, Anders Josefsson, Jing Yu, Angel Cortez, Remco Bastiaannet, Esteban Velarde, Cory Brayton, Hao Wang, Julien Torgue, Robert Hobbs and George Sgouros

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4062;
You have access
Chlorin e6-Loaded Goat Milk-derived Extracellular Vesicles for Cerenkov Luminescence-induced Photodynamic Therapy
Rong Guo, Yongkang Gai, Dawei Jiang, Xiaoli Lan and Rui An

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4042;
You have access
PET imaging of mesothelioma in mouse models with a clinical stage CD46 targeting human monoclonal antibody
Jun Li, Yang Su, Ping Chen, Bin Liu and Jiang He

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4046;
You have access
Noninvasive monitoring of treatment response in lung cancer using F-18 labeled Fluorodeoxyglucarate
Junling Li, Huaiyu Zheng, Alexis Vega, Levi Beverly, Brian Gray, Koon Pak and Chin Ng

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4018;
You have access
Evaluation of receptor-specific radiotracer binding in the HET-CAM model by PET-MRI with inhibition studies
Jessica Loeffler, Carmen Hamp, Christoph Solbach, Mareike Wirth, Gerhard Glatting, Volker Rasche, Ambros Beer and Gordon Winter

Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 4034;

Main menu

User menu

Search

More articles from In vitro and In vivo Oncology

Pages